Open access · US-GOV via ClinicalTrials.gov Clinical trial

CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Authors not listed

Vanderbilt-Ingram Cancer Center · 2022

Dysbiosis Human Randomized controlled trial

＋ Sign in to save

Abstract

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-13 MST

Cite this

APA

Anonymous. (2022). CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan. <em>Vanderbilt-Ingram Cancer Center</em>. https://clinicaltrials.gov/study/NCT06482957

Vancouver

Anonymous. CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan. Vanderbilt-Ingram Cancer Center. 2022.

BibTeX

@misc{anon2022CAUSAL, title = {CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan}, author = {Anonymous}, journal = {Vanderbilt-Ingram Cancer Center}, year = {2022}, }